p53 Is Active in Human Amniotic Fluid Stem Cells

Stem Cells Dev. 2018 Nov 1;27(21):1507-1517. doi: 10.1089/scd.2017.0254. Epub 2018 Oct 2.

Abstract

Despite increasing interest in human amniotic fluid cells, very little is known about the regulation and function of p53 in this cell type. In this study, we show that undifferentiated human amniotic fluid cells express p53, yet at lower levels than in cancer cells. The p53 protein in amniotic fluid cells is mainly localized in the nuclei, however, its antiproliferative activity is compromised in these cells. Igf2, a maternal imprinted gene, and c-jun, a proto-oncogene, are regulated by p53 in these cells. DNA damage leads to an increase in p53 abundance in human amniotic fluid cells and to transcriptional activation of its target genes. Interestingly, cell differentiation toward the neural lineage leads to p53 induction as differentiation progresses.

Keywords: DNA damage response; amniotic fluid cells; apoptosis; differentiation; p53; proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amniotic Fluid / cytology*
  • Amniotic Fluid / metabolism
  • Cell Differentiation / genetics
  • Cell Line
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Cell Proliferation / genetics
  • DNA Damage / genetics
  • Gene Expression Regulation, Developmental
  • Genomic Imprinting / genetics*
  • Humans
  • Insulin-Like Growth Factor II / genetics*
  • JNK Mitogen-Activated Protein Kinases / genetics
  • Neurons / cytology
  • Neurons / metabolism
  • Proto-Oncogene Mas
  • Stem Cells / cytology*
  • Stem Cells / metabolism
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • IGF2 protein, human
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Insulin-Like Growth Factor II
  • JNK Mitogen-Activated Protein Kinases